Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales fréquentes
Nom anglais: Solute Carrier Family 12, Member 4
Descriptor UI:D064507
Tree Number:D12.776.543.585.937.875.875
Termes MeSH sélectionnés :
Reproducibility of Results
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales les plus fréquentes",
"headline": "Membre-4 de la famille-12 des transporteurs de solutés : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Membre-4 de la famille-12 des transporteurs de solutés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Membre-4 de la famille-12 des transporteurs de solutés"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Symporteurs des ions sodium-potassium-chlorure",
"url": "https://questionsmedicales.fr/mesh/D028021",
"about": {
"@type": "MedicalCondition",
"name": "Symporteurs des ions sodium-potassium-chlorure",
"code": {
"@type": "MedicalCode",
"code": "D028021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937.875"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Membre-4 de la famille-12 des transporteurs de solutés",
"alternateName": "Solute Carrier Family 12, Member 4",
"code": {
"@type": "MedicalCode",
"code": "D064507",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Simon Franz Müller",
"url": "https://questionsmedicales.fr/author/Simon%20Franz%20M%C3%BCller",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany."
}
},
{
"@type": "Person",
"name": "Joachim Geyer",
"url": "https://questionsmedicales.fr/author/Joachim%20Geyer",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany."
}
},
{
"@type": "Person",
"name": "Nipaporn Deejai",
"url": "https://questionsmedicales.fr/author/Nipaporn%20Deejai",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Choochai Nettuwakul",
"url": "https://questionsmedicales.fr/author/Choochai%20Nettuwakul",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Nunghathai Sawasdee",
"url": "https://questionsmedicales.fr/author/Nunghathai%20Sawasdee",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Risk stratification of hospital admissions for COVID-19 pneumonia by chest radiographic scoring in a Johannesburg tertiary hospital.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36757072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7196/SAMJ.2023.v113i2.16681"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of Performance Characteristics of the Aptima CMV Quant Assay for the Detection and Quantitation of CMV DNA in Plasma Samples.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36719219",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/jcm.01699-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of lncRNA-miRNA-mRNA Regulatory Network and Therapeutic Agents for Skin Aging by Bioinformatics Analysis.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36719625",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10528-023-10334-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Validation study of WindTrax reverse dispersion model coupled with a sensitivity analysis of model-specific settings.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36731598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envres.2023.115401"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item distribution, scalability and internal consistency of the QUALIDEM quality of life assessment for patients with dementia in acute hospital settings.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36721226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12955-023-02094-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport membranaire",
"item": "https://questionsmedicales.fr/mesh/D026901"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines transporteurs de solutés",
"item": "https://questionsmedicales.fr/mesh/D000070590"
},
{
"@type": "ListItem",
"position": 7,
"name": "Symporteurs des ions sodium-potassium-chlorure",
"item": "https://questionsmedicales.fr/mesh/D028021"
},
{
"@type": "ListItem",
"position": 8,
"name": "Membre-4 de la famille-12 des transporteurs de solutés",
"item": "https://questionsmedicales.fr/mesh/D064507"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Membre-4 de la famille-12 des transporteurs de solutés - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Comment diagnostiquer une dysfonction de SLC12A4 ?\nQuels tests sont utilisés pour évaluer SLC12A4 ?\nY a-t-il des marqueurs spécifiques pour SLC12A4 ?\nLes imageries médicales aident-elles au diagnostic ?\nLe diagnostic nécessite-t-il une biopsie ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Quels sont les symptômes d'une anomalie de SLC12A4 ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes sont-ils toujours présents ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Comment prévenir les troubles liés à SLC12A4 ?\nY a-t-il des tests de dépistage recommandés ?\nLes conseils génétiques sont-ils utiles ?\nLes vaccinations influencent-elles SLC12A4 ?\nL'exercice physique aide-t-il à prévenir les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Quels traitements sont disponibles pour SLC12A4 ?\nLa thérapie génique est-elle une option ?\nLes changements alimentaires aident-ils ?\nDes traitements symptomatiques existent-ils ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Quelles complications peuvent survenir avec SLC12A4 ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nDes soins palliatifs sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Membre-4 de la famille-12 des transporteurs de solutés",
"description": "Quels sont les facteurs de risque pour SLC12A4 ?\nL'environnement influence-t-il SLC12A4 ?\nLe mode de vie joue-t-il un rôle ?\nLes infections augmentent-elles le risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=995#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction de SLC12A4 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses biochimiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer SLC12A4 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de transport ionique et des analyses de sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour SLC12A4 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de marqueurs spécifiques largement reconnus."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les imageries peuvent aider à évaluer des anomalies, mais ne sont pas spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il une biopsie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie n'est généralement pas nécessaire pour diagnostiquer SLC12A4."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une anomalie de SLC12A4 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des déséquilibres électrolytiques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les signes de déshydratation et de fatigue excessive."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques malgré une anomalie."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés à SLC12A4 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et une hydratation adéquate peuvent aider à prévenir les troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être recommandés pour les familles à risque."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider à évaluer le risque familial."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles SLC12A4 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations n'ont pas d'impact direct sur SLC12A4."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les symptômes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un exercice régulier peut contribuer à une meilleure santé globale, mais pas spécifique."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour SLC12A4 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des suppléments électrolytiques et des médicaments spécifiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime équilibré peut aider à gérer les déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "Des traitements symptomatiques existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements symptomatiques peuvent être prescrits pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec SLC12A4 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles rénaux et des déséquilibres électrolytiques graves."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies métaboliques peuvent être associées à des anomalies de SLC12A4."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Des soins palliatifs sont-ils nécessaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, des soins palliatifs peuvent être envisagés pour le confort."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour SLC12A4 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines conditions génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement influence-t-il SLC12A4 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent influencer l'expression de SLC12A4."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut exacerber les problèmes liés à SLC12A4."
}
},
{
"@type": "Question",
"name": "Les infections augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent aggraver les symptômes liés à SLC12A4."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut influencer la gravité des symptômes et des complications."
}
}
]
}
]
}
Chest radiographic scoring systems for COVID-19 pneumonia have been developed. However, little is published on the utilityof these scoring systems in low- and middle-income countries....
To perform risk stratification of COVID-19 pneumonia in Johannesburg, South Africa (SA), by comparing the Brixia score withclinical parameters, disease course and clinical outcomes. To assess inter-ra...
Retrospective investigation was conducted of adult participants with established COVID-19 pneumonia admitted at a tertiaryinstitution from 1 May to 30 June 2020. Two radiologists, blinded to clinical ...
The cohort consisted of 263 patients, 51% male, with a median age of 47 years (interquartile range (IQR) = 20; 95% confidenceinterval (CI) 46.5 - 49.9). Hypertension (38.4%), diabetes (25.1%), obesity...
We have demonstrated the utility of the Brixia scoring system in a middle-income country setting and developed the first SArisk stratification models incorporating comorbidities and a serological mark...
Quantification of Cytomegalovirus (CMV) DNA has become the standard of care in the diagnosis and management of CMV infection in transplant recipients. The objective of the study was to evaluate perfor...
Skin aging is the most intuitive manifestation of aging. Skin aging inevitably leads to cosmetic and psychological problems, and even diseases. The present study aims to research the pathological and ...
In last years, atmospheric dispersion models have reached considerable popularity in environmental research field. In this regard, given the difficulties associated to the estimation of emission rate ...
Quality of life (QoL) of people with dementia (PwD) is an important indicator of quality of care. Studying the impact of acute hospital settings on PwD's QoL requires assessment instruments that consi...
Data stem from a study that analyzed the impact of a special care concept on the QoL of patients with dementia in acute hospitals. Total sample size consisted of N = 526 patients. Study nurses were tr...
For people with mild to severe dementia, seven out of nine subscales were scalable (0.31 ≤ H ≤ 0.75). Five of these seven subscales were also internally consistent (ρ ≥ 0.69), while two had insufficie...
In comparison with a previous evaluation of the QUALIDEM in a long-term care setting, the application in a hospital setting leads to very similar, acceptable results for people with mild to severe dem...
Helicobacter pylori (H. pylori) is a kind of microaerobic and food-borne pathogen. More than 4.4 billion individuals have been infected by H. pylori and H. pylori was listed as Group I carcinogen by W...
The rapid diagnosis and detection of respiratory bacteria at the early stage can effectively control the epidemic spread and bacterial infection. Here, we designed a rapid, ultrasensitive, and quantit...
Deep neural networks (DNNs) have the powerful ability to automatically extract efficient features, which makes them prominent in electroencephalogram (EEG) based seizure prediction tasks. However, cur...
In numerous perilous cases, a quick medical decision is needed for the early detection of chronic diseases to avoid austere consequences that may be fatal. Chronic kidney disease (CKD) is a prevalent ...
Mohs micrographic surgery (MMS) for melanoma practices vary among dermatologic surgeons. The implementation of immunohistochemical staining in MMS for melanoma mitigates challenges associated with sli...
To assess concordance rates of MART-1 frozen sections and permanent section pathologic interpretation of melanoma treated with MMS....
A dual-center retrospective analysis was conducted to collect concordance and demographic data. Chi-square tests were performed for group comparisons of categorical variables....
Of the 379 permanent sections sent, 367 were concordant with frozen section pathology for an overall concordance rate of 96.8%. Cases were stratified into indeterminately concordant and indisputably c...
The concordance rate is derived from a comparison of adjacent tissue margins, an inevitable consequence of utilizing 2 techniques....
To the author's knowledge, this study represents the largest investigation examining concordance rates of MART-1 frozen sections in Mohs for melanoma. High concordance disputes the ongoing need for ad...